arrow
B

Bas Groot Koerkamp

Erasmus Medical Center
H指数:81
被引数:2.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic impact of severe postoperative complications after curative-intent resection for perihilar cholangiocarcinoma: an international multi-institutional analysis

根治性切除术后严重并发症对肝门部胆管癌预后的影响:一项国际多中心分析

HPB
IF2.4
2026-08-220
OAAI
Impact of pathological diagnosis on postoperative outcomes after pancreatoduodenectomy: A nationwide cohort study

胰腺十二指肠切除术后病理诊断对预后的影响:一项全国性队列研究

EJSO
IF2.9
2026-07-010
OAAI
Surgical outcomes from nationwide implementation of the international best practice for locally advanced pancreatic cancer (PREOPANC-4) study

国际最佳实践在局部晚期胰腺癌中的全国性实施研究(PREOPANC-4)的手术结果

2026-06-220
OAAI
Genotype-Phenotype Associations Underlying Very Early Recurrence After Intrahepatic Cholangiocarcinoma Resection

肝内胆管癌切除术后极早期复发的基因型-表型关联

2026-05-010
PRE
Clinical implications of an intraoperative margin-positive distal bile duct in perihilar cholangiocarcinoma: international multicentre cohort study

肝门部胆管癌术中切缘阳性的远端胆管切除的临床意义:一项国际多中心队列研究

2026-03-230
OA
The Value of Stereotactic Radiotherapy After FOLFIRINOX in Patients with Pancreatic Cancer with Vascular Contact-A Nationwide, Retrospective Cohort Study

血管接触的胰腺癌患者FOLFIRINOX治疗后立体定向放射治疗的价值——一项全国性回顾性队列研究

Cancers
IF4.4
2026-02-200
OA
Cholangiocarcinoma 2026: status quo, unmet needs and priorities

胆管癌2026: 现状,未满足的需求和优先事项

2025-12-100
OAAI
Staging laparoscopy to detect occult metastases in localized pancreatic cancer: global survey among nine international societies

局部胰腺癌中用于检测隐匿性转移的分期腹腔镜:九个国际学会的全球调查

HPB
IF2.4
2025-12-060
OAAI
Survival benefit of adjuvant chemotherapy for perihilar cholangiocarcinoma: Impact of log odds of metastatic lymph node count

辅助化疗对肝门部胆管癌的生存获益:转移淋巴结计数对数优势比的影响

Surgery
IF2.7
2025-12-010
PRE
Delayed gastric emptying after pancreatic cancer surgery impacts time to start of adjuvant treatment but not overall survival: a post-hoc analysis of the PREOPANC-1 and-2 trials

胰腺癌手术后胃排空延迟影响辅助治疗开始时间,但不影响总生存期:一项对PREOPANC-1和-2试验的事后分析

2025-12-010
PRE
Minimally Invasive versus Open Pancreatoduodenectomy for Resectable Neoplasms
2025-11-255
PRE
ASO Visual Abstract: Impact of Different Primary Treatment Strategies on Recurrence-Focused Treatment of Pancreatic Ductal Adenocarcinoma

ASO视觉摘要:不同初始治疗策略对胰腺导管腺癌复发导向治疗的影响

2025-11-250
PRE
Impact of Different Primary Treatment Strategies on Recurrence-Focused Treatment of Pancreatic Ductal Adenocarcinoma

不同初级治疗策略对复发导向的胰腺导管腺癌治疗的影响

2025-11-070
PRE
10-year survival after resection of pancreatic ductal adenocarcinoma with pathological re-examination of a nationwide cohort

胰腺导管腺癌切除术后10年生存率:基于全国队列病理复检的研究

2025-11-060
OAAI